{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:58:49Z","timestamp":1780509529015,"version":"3.54.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UH3TR003289"],"award-info":[{"award-number":["UH3TR003289"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U24TR002632"],"award-info":[{"award-number":["U24TR002632"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U24TR002632"],"award-info":[{"award-number":["U24TR002632"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U24TR002632"],"award-info":[{"award-number":["U24TR002632"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UH3DK119973"],"award-info":[{"award-number":["UH3DK119973"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK117881"],"award-info":[{"award-number":["R01DK117881"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK135606"],"award-info":[{"award-number":["R01DK135606"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UH3DK119973"],"award-info":[{"award-number":["UH3DK119973"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["S10OD028450"],"award-info":[{"award-number":["S10OD028450"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000146","name":"NSF | ENG\/OAD | Division of Chemical, Bioengineering, Environmental, and Transport Systems","doi-asserted-by":"publisher","award":["1706674"],"award-info":[{"award-number":["1706674"]}],"id":[{"id":"10.13039\/100000146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000146","name":"NSF | ENG\/OAD | Division of Chemical, Bioengineering, Environmental, and Transport Systems","doi-asserted-by":"publisher","award":["2229156"],"award-info":[{"award-number":["2229156"]}],"id":[{"id":"10.13039\/100000146","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-07006-7","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T20:01:58Z","timestamp":1728849718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7530-3303","authenticated-orcid":false,"given":"Julio","family":"Aleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Schurdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-3167","authenticated-orcid":false,"given":"Lawrence","family":"Vernetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"Gavlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"DeBiasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"LaRocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulder Daniel","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-0195","authenticated-orcid":false,"given":"Albert","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Soto-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaideep","family":"Behari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-6784","authenticated-orcid":false,"given":"Vijay K.","family":"Yechoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-6032","authenticated-orcid":false,"given":"Mark T.","family":"Miedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipsita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-1343","authenticated-orcid":false,"given":"D. Lansing","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"7006_CR1","unstructured":"Control, C. f. D. & Prevention. National diabetes statistics report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services (2017)."},{"key":"7006_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2337\/dc12-2625","volume":"36","author":"American Diabetes, A.","year":"2013","unstructured":"American Diabetes, A. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36, 1033\u20131046 (2013).","journal-title":"Diabetes Care"},{"key":"7006_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA Defronzo","year":"2009","unstructured":"Defronzo, R. A. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58, 773\u2013795 (2009).","journal-title":"Diabetes"},{"key":"7006_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.bbapap.2013.08.004","volume":"1844","author":"S Hartwig","year":"2014","unstructured":"Hartwig, S. et al. Secretome profiling of primary human skeletal muscle cells. Biochim Biophys. Acta 1844, 1011\u20131017 (2014).","journal-title":"Biochim Biophys. Acta"},{"key":"7006_CR5","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nm.2513","volume":"17","author":"H Ellingsgaard","year":"2011","unstructured":"Ellingsgaard, H. et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat. Med. 17, 1481 (2011).","journal-title":"Nat. Med."},{"key":"7006_CR6","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1096\/fj.14-264820","volume":"29","author":"FM Paula","year":"2015","unstructured":"Paula, F. M. et al. Exercise increases pancreatic \u03b2-cell viability in a model of type 1 diabetes through IL-6 signaling. FASEB J. 29, 1805\u20131816 (2015).","journal-title":"FASEB J."},{"key":"7006_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m, P. et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463 (2012).","journal-title":"Nature"},{"key":"7006_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cmet.2013.12.017","volume":"19","author":"P Lee","year":"2014","unstructured":"Lee, P. et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 19, 302\u2013309 (2014).","journal-title":"Cell Metab."},{"key":"7006_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coph.2017.05.005","volume":"34","author":"J Giudice","year":"2017","unstructured":"Giudice, J. & Taylor, J. M. Muscle as a paracrine and endocrine organ. Curr. Opin. Pharm. 34, 49\u201355 (2017).","journal-title":"Curr. Opin. Pharm."},{"key":"7006_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425 (1994).","journal-title":"Nature"},{"key":"7006_CR11","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"PE Scherer","year":"1995","unstructured":"Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746\u201326749 (1995).","journal-title":"J. Biol. Chem."},{"key":"7006_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ecl.2008.07.002","volume":"37","author":"N Halberg","year":"2008","unstructured":"Halberg, N., Wernstedt-Asterholm, I. & Scherer, P. E. The adipocyte as an endocrine cell. Endocrinol. Metab. Clin. 37, 753\u2013768 (2008).","journal-title":"Endocrinol. Metab. Clin."},{"key":"7006_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/prca.201100052","volume":"6","author":"S Lehr","year":"2012","unstructured":"Lehr, S., Hartwig, S. & Sell, H. Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteom. Clin. Appl 6, 91\u2013101 (2012).","journal-title":"Proteom. Clin. Appl"},{"key":"7006_CR14","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.010504","volume":"11","author":"S Lehr","year":"2012","unstructured":"Lehr, S. et al. Identification and validation of novel adipokines released from primary human adipocytes. Mol. Cell Proteom. 11, M111 010504 (2012).","journal-title":"Mol. Cell Proteom."},{"key":"7006_CR15","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1210\/jc.2016-2308","volume":"101","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. Association between serum fibroblast growth factor 21 and mortality among patients with coronary artery disease. J. Clin. Endocrinol. Metab. 101, 4886\u20134894 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7006_CR16","doi-asserted-by":"publisher","first-page":"E1325","DOI":"10.1210\/jc.2011-0620","volume":"96","author":"S Yang","year":"2011","unstructured":"Yang, S. et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J. Clin. Endocrinol. Metab. 96, E1325\u2013E1329 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7006_CR17","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Investig. 115, 1627\u20131635 (2005).","journal-title":"J. Clin. Investig."},{"key":"7006_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","volume":"22","author":"RC Meex","year":"2015","unstructured":"Meex, R. C. et al. Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism. Cell Metab. 22, 1078\u20131089 (2015).","journal-title":"Cell Metab."},{"key":"7006_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex, R. C. R. & Watt, M. J. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat. Rev. Endocrinol. 13, 509\u2013520 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"7006_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","volume":"38","author":"MC Calle","year":"2012","unstructured":"Calle, M. C. & Fernandez, M. L. Inflammation and type 2 diabetes. Diabetes Metab. 38, 183\u2013191 (2012).","journal-title":"Diabetes Metab."},{"key":"7006_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98\u2013107 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"7006_CR22","doi-asserted-by":"publisher","unstructured":"Ciardullo, S., Vergani, M. & Perseghin, G. Nonalcoholic fatty liver disease in patients with type 2 diabetes: screening, diagnosis, and treatment. J. Clin. Med. 12, https:\/\/doi.org\/10.3390\/jcm12175597 (2023).","DOI":"10.3390\/jcm12175597"},{"key":"7006_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/liv.13994","volume":"39","author":"AE Morrison","year":"2019","unstructured":"Morrison, A. E., Zaccardi, F., Khunti, K. & Davies, M. J. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis. Liver Int. 39, 557\u2013567 (2019).","journal-title":"Liver Int."},{"key":"7006_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher, G., Corey, K. E., Byrne, C. D. & Roden, M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat. Rev. Gastroenterol. Hepatol. 18, 599\u2013612 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7006_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"7006_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg, H., Moschen, A. R. & Roden, M. NAFLD and diabetes mellitus. Nat. Rev. Gastroenterol. Hepatol. 14, 32\u201342 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7006_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cmet.2015.12.001","volume":"23","author":"A El Ouaamari","year":"2016","unstructured":"El Ouaamari, A. et al. SerpinB1 promotes pancreatic \u03b2 cell proliferation. Cell Metab. 23, 194\u2013205 (2016).","journal-title":"Cell Metab."},{"key":"7006_CR28","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","volume":"18","author":"D Pal","year":"2012","unstructured":"Pal, D. et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 18, 1279\u20131285 (2012).","journal-title":"Nat. Med."},{"key":"7006_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00888-8","author":"E Scoditti","year":"2024","unstructured":"Scoditti, E., Sabatini, S., Carli, F. & Gastaldelli, A. Hepatic glucose metabolism in the steatotic liver. Nat. Rev. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1038\/s41575-023-00888-8 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7006_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892672","volume":"13","author":"L Lopez-Bermudo","year":"2022","unstructured":"Lopez-Bermudo, L. et al. Contribution of liver and pancreatic islet crosstalk to beta-cell function\/dysfunction in the presence of fatty liver. Front. Endocrinol. (Lausanne) 13, 892672 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"7006_CR31","doi-asserted-by":"publisher","unstructured":"Flessa, C. M. et al. Genetic and diet-induced animal models for non-alcoholic fatty liver disease (NAFLD) Research. Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms232415791 (2022).","DOI":"10.3390\/ijms232415791"},{"key":"7006_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","volume":"8","author":"L Hebbard","year":"2011","unstructured":"Hebbard, L. & George, J. Animal models of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 8, 35\u201344 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7006_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrendo.2017.161","volume":"14","author":"M Kleinert","year":"2018","unstructured":"Kleinert, M. et al. Animal models of obesity and diabetes mellitus. Nat. Rev. Endocrinol. 14, 140\u2013162 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"7006_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41684-019-0311-0","volume":"48","author":"EP Neff","year":"2019","unstructured":"Neff, E. P. Farewell, FATZO: a NASH mouse update. Lab Anim. (NY) 48, 151 (2019).","journal-title":"Lab Anim. (NY)"},{"key":"7006_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41575-023-00796-x","volume":"20","author":"PN Brennan","year":"2023","unstructured":"Brennan, P. N. et al. Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach. Nat. Rev. Gastroenterol. Hepatol. 20, 679\u2013688 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7006_CR36","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1039\/C8LC00418H","volume":"18","author":"X Li","year":"2018","unstructured":"Li, X., George, S. M., Vernetti, L., Gough, A. H. & Taylor, D. L. A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME\/TOX. Lab Chip 18, 2614\u20132631 (2018).","journal-title":"Lab Chip"},{"key":"7006_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1535370215592121","volume":"241","author":"LA Vernetti","year":"2016","unstructured":"Vernetti, L. A. et al. A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Exp. Biol. Med. (Maywood) 241, 101\u2013114 (2016).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"7006_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.478","volume":"2","author":"Q Shi","year":"2022","unstructured":"Shi, Q. et al. Co-culture of human primary hepatocytes and nonparenchymal liver cells in the emulate(R) liver-chip for the study of drug-induced liver injury. Curr. Protoc. 2, e478 (2022).","journal-title":"Curr. Protoc."},{"key":"7006_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1208\/s12248-023-00870-x","volume":"25","author":"SAP Rajan","year":"2023","unstructured":"Rajan, S. A. P. et al. A novel milli-fluidic liver tissue chip with continuous recirculation for predictive pharmacokinetics applications. AAPS J. 25, 102 (2023).","journal-title":"AAPS J."},{"key":"7006_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","volume":"30","author":"R Ouchi","year":"2019","unstructured":"Ouchi, R. et al. Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids. Cell Metab. 30, 374\u2013384 e376 (2019).","journal-title":"Cell Metab."},{"key":"7006_CR41","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s42003-021-02616-x","volume":"4","author":"T Kostrzewski","year":"2021","unstructured":"Kostrzewski, T. et al. Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system. Commun. Biol. 4, 1080 (2021).","journal-title":"Commun. Biol."},{"key":"7006_CR42","doi-asserted-by":"publisher","unstructured":"Kang, S. Y. et al. A pillar and perfusion plate platform for robust human organoid culture and analysis. Adv. Healthc. Mater, e2302502, https:\/\/doi.org\/10.1002\/adhm.202302502 (2023).","DOI":"10.1002\/adhm.202302502"},{"key":"7006_CR43","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1039\/D3LC00838J","volume":"24","author":"K Schlunder","year":"2024","unstructured":"Schlunder, K. et al. Microphysiological pancreas-on-chip platform with integrated sensors to model endocrine function and metabolism. Lab Chip 24, 2080\u20132093 (2024).","journal-title":"Lab Chip"},{"key":"7006_CR44","doi-asserted-by":"publisher","unstructured":"Patel, S. N. et al. Organoid microphysiological system preserves pancreatic islet function within 3D matrix. Sci. Adv. 7, https:\/\/doi.org\/10.1126\/sciadv.aba5515 (2021).","DOI":"10.1126\/sciadv.aba5515"},{"key":"7006_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4520","volume":"5","author":"Y Jun","year":"2019","unstructured":"Jun, Y. et al. In vivo-mimicking microfluidic perfusion culture of pancreatic islet spheroids. Sci. Adv. 5, eaax4520 (2019).","journal-title":"Sci. Adv."},{"key":"7006_CR46","unstructured":"Wiegand, C. R. Pancreatic Islet Microphysiology System for Disease Modeling of Type 2 Diabetes, University of Pittsburgh (2023)."},{"key":"7006_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14815-w","volume":"7","author":"S Bauer","year":"2017","unstructured":"Bauer, S. et al. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Sci. Rep. 7, 14620 (2017).","journal-title":"Sci. Rep."},{"key":"7006_CR48","doi-asserted-by":"publisher","unstructured":"Aizenshtadt, A. et al. Pump-Less, Recirculating Organ-on-Chip (rOoC) Platform to Model the Metabolic Crosstalk between Islets and Liver. Adv. Healthc. Mater. e2303785, https:\/\/doi.org\/10.1002\/adhm.202303785 (2024).","DOI":"10.1002\/adhm.202303785"},{"key":"7006_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202213649","volume":"33","author":"JJ Kim","year":"2023","unstructured":"Kim, J. J. et al. Pathophysiological reconstruction of a tissue\u2010specific multiple\u2010organ on\u2010a\u2010chip for Type 2 diabetes emulation using 3D cell printing. Adv. Funct. Mater. 33, 2213649 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"7006_CR50","volume":"9","author":"T Tao","year":"2022","unstructured":"Tao, T. et al. Microengineered multi-organoid system from hiPSCs to recapitulate human liver-islet axis in normal and type 2 diabetes. Adv. Sci. (Weinh.) 9, e2103495 (2022).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"7006_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41575-020-00386-1","volume":"18","author":"A Gough","year":"2021","unstructured":"Gough, A. et al. Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat. Rev. Gastroenterol. Hepatol. 18, 252\u2013268 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7006_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.celrep.2013.01.007","volume":"3","author":"A El Ouaamari","year":"2013","unstructured":"El Ouaamari, A. et al. Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep. 3, 401\u2013410 (2013).","journal-title":"Cell Rep."},{"key":"7006_CR53","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1039\/C9LC01047E","volume":"20","author":"M Schurdak","year":"2020","unstructured":"Schurdak, M. et al. Applications of the microphysiology systems database for experimental ADME-Tox and disease models. Lab Chip 20, 1472\u20131492 (2020).","journal-title":"Lab Chip"},{"key":"7006_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152651","volume":"448","author":"C Sakolish","year":"2021","unstructured":"Sakolish, C. et al. Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS). Toxicology 448, 152651 (2021).","journal-title":"Toxicology"},{"key":"7006_CR55","unstructured":"Miedel, M. T. et al. Reproducibility Analytics and Metadata are Required to Qualify Microphysiology Systems for Interpreting Biologically\/Clinically Relevant Heterogeneity for Precision Medicine. bioRxiv (2024)."},{"key":"7006_CR56","doi-asserted-by":"publisher","unstructured":"Xia, M. et al. Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy. Front. Cell Dev. Biol. 12, https:\/\/doi.org\/10.3389\/fcell.2024.1423936 (2024).","DOI":"10.3389\/fcell.2024.1423936"},{"key":"7006_CR57","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1177\/15353702211009228","volume":"246","author":"M Saydmohammed","year":"2021","unstructured":"Saydmohammed, M. et al. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Exp. Biol. Med. (Maywood) 246, 2420\u20132441 (2021).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"7006_CR58","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1177\/1535370217703978","volume":"242","author":"FT Lee-Montiel","year":"2017","unstructured":"Lee-Montiel, F. T. et al. Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems. Exp. Biol. Med. (Maywood) 242, 1617\u20131632 (2017).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"7006_CR59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41575-019-0134-x","volume":"16","author":"S Ben-Moshe","year":"2019","unstructured":"Ben-Moshe, S. & Itzkovitz, S. Spatial heterogeneity in the mammalian liver. Nat. Rev. Gastroenterol. Hepatol. 16, 395\u2013410 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7006_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biochi.2013.06.007","volume":"96","author":"BS Hijmans","year":"2014","unstructured":"Hijmans, B. S., Grefhorst, A., Oosterveer, M. H. & Groen, A. K. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences. Biochimie 96, 121\u2013129 (2014).","journal-title":"Biochimie"},{"key":"7006_CR61","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41366-018-0062-9","volume":"42","author":"M Honma","year":"2018","unstructured":"Honma, M. et al. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. Int J. Obes. (Lond.) 42, 1544\u20131555 (2018).","journal-title":"Int J. Obes. (Lond.)"},{"key":"7006_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10715762.2019.1702656","volume":"54","author":"GBN Chainy","year":"2020","unstructured":"Chainy, G. B. N. & Sahoo, D. K. Hormones and oxidative stress: an overview. Free Radic. Res. 54, 1\u201326 (2020).","journal-title":"Free Radic. Res."},{"key":"7006_CR63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2337\/db07-1056","volume":"58","author":"C Leloup","year":"2009","unstructured":"Leloup, C. et al. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 58, 673\u2013681 (2009).","journal-title":"Diabetes"},{"key":"7006_CR64","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/febs.16306","volume":"290","author":"JM Sanches","year":"2023","unstructured":"Sanches, J. M., Zhao, L. N., Salehi, A., Wollheim, C. B. & Kaldis, P. Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. FEBS J. 290, 620\u2013648 (2023).","journal-title":"FEBS J."},{"key":"7006_CR65","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00125-022-05673-x","volume":"65","author":"MS Nguyen-Tu","year":"2022","unstructured":"Nguyen-Tu, M. S. et al. Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase. Diabetologia 65, 997\u20131011 (2022).","journal-title":"Diabetologia"},{"key":"7006_CR66","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s12664-021-01176-6","volume":"40","author":"PG Yamasandhi","year":"2021","unstructured":"Yamasandhi, P. G., Dharmalingam, M. & Balekuduru, A. Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease. Indian J. Gastroenterol. 40, 556\u2013562 (2021).","journal-title":"Indian J. Gastroenterol."},{"key":"7006_CR67","doi-asserted-by":"publisher","unstructured":"Dogru, T. et al. The evolving role of fetuin-a in nonalcoholic fatty liver disease: an overview from liver to the heart. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22126627 (2021).","DOI":"10.3390\/ijms22126627"},{"key":"7006_CR68","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.2337\/db08-0538","volume":"57","author":"N Stefan","year":"2008","unstructured":"Stefan, N. et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57, 2762\u20132767 (2008).","journal-title":"Diabetes"},{"key":"7006_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0303-7207(00)00237-9","volume":"164","author":"ST Mathews","year":"2000","unstructured":"Mathews, S. T. et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol. Cell Endocrinol. 164, 87\u201398 (2000).","journal-title":"Mol. Cell Endocrinol."},{"key":"7006_CR70","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.2337\/diabetes.51.8.2450","volume":"51","author":"ST Mathews","year":"2002","unstructured":"Mathews, S. T. et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51, 2450\u20132458 (2002).","journal-title":"Diabetes"},{"key":"7006_CR71","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","volume":"29","author":"N Stefan","year":"2006","unstructured":"Stefan, N. et al. Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29, 853\u2013857 (2006).","journal-title":"Diabetes Care"},{"key":"7006_CR72","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.12.011","volume":"25","author":"AS Goustin","year":"2013","unstructured":"Goustin, A. S., Derar, N. & Abou-Samra, A. B. Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD beta-subunit of the insulin receptor. Cell Signal. 25, 981\u2013988 (2013).","journal-title":"Cell Signal."},{"key":"7006_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111314","volume":"532","author":"A Mukhuty","year":"2021","unstructured":"Mukhuty, A., Fouzder, C. & Kundu, R. Blocking TLR4-NF-kappaB pathway protects mouse islets from the combinatorial impact of high fat and fetuin-A mediated dysfunction and restores ability for insulin secretion. Mol. Cell Endocrinol. 532, 111314 (2021).","journal-title":"Mol. Cell Endocrinol."},{"key":"7006_CR74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2023.01.070","volume":"647","author":"S Nag","year":"2023","unstructured":"Nag, S., Mandal, S., Majumdar, T., Mukhopadhyay, S. & Kundu, R. FFA-Fetuin-A regulates DPP-IV expression in pancreatic beta cells through TLR4-NFkB pathway. Biochem Biophys. Res Commun. 647, 55\u201361 (2023).","journal-title":"Biochem Biophys. Res Commun."},{"key":"7006_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.934775","volume":"13","author":"MM Holter","year":"2022","unstructured":"Holter, M. M., Saikia, M. & Cummings, B. P. Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion. Front Endocrinol. (Lausanne) 13, 934775 (2022).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"7006_CR76","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1007\/s00125-017-4385-1","volume":"60","author":"F Gerst","year":"2017","unstructured":"Gerst, F. et al. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion. Diabetologia 60, 2240\u20132251 (2017).","journal-title":"Diabetologia"},{"key":"7006_CR77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4093\/dmj.2020.0222","volume":"46","author":"ZH Zhang","year":"2022","unstructured":"Zhang, Z. H. et al. Serum retinol-binding protein levels are associated with nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus: a real-world study. Diabetes Metab. J. 46, 129\u2013139 (2022).","journal-title":"Diabetes Metab. J."},{"key":"7006_CR78","doi-asserted-by":"publisher","unstructured":"Flores-Cortez, Y. A. et al. Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review). Mol. Med. Rep. 26, https:\/\/doi.org\/10.3892\/mmr.2022.12760 (2022).","DOI":"10.3892\/mmr.2022.12760"},{"key":"7006_CR79","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2337\/db19-1241","volume":"70","author":"R Huang","year":"2021","unstructured":"Huang, R., Bai, X., Li, X., Wang, X. & Zhao, L. Retinol-Binding Protein 4 Activates STRA6, Provoking Pancreatic beta-Cell Dysfunction in Type 2 Diabetes. Diabetes 70, 449\u2013463 (2021).","journal-title":"Diabetes"},{"key":"7006_CR80","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/19382014.2021.1889941","volume":"13","author":"SA Campbell","year":"2021","unstructured":"Campbell, S. A., Johnson, J. & Light, P. E. Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1. Islets 13, 32\u201350 (2021).","journal-title":"Islets"},{"key":"7006_CR81","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2337\/dc07-2433","volume":"31","author":"JJ Hwang","year":"2008","unstructured":"Hwang, J. J., Chan, J. L., Ntali, G., Malkova, D. & Mantzoros, C. S. Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans. Diabetes Care 31, 945\u2013951 (2008).","journal-title":"Diabetes Care"},{"key":"7006_CR82","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF00495805","volume":"77","author":"R Fiocca","year":"1983","unstructured":"Fiocca, R. et al. Pancreatic polypeptide (PP) cells in the PP-rich lobe of the human pancreas are identified ultrastructurally and immunocytochemically as F cells. Histochemistry 77, 511\u2013523 (1983).","journal-title":"Histochemistry"},{"key":"7006_CR83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput, W., Mes, J. J. & Wichers, H. J. THP-1 cell line: an in vitro cell model for immune modulation approach. Int. Immunopharmacol. 23, 37\u201345 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"7006_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.112721","volume":"478","author":"EW Baxter","year":"2020","unstructured":"Baxter, E. W. et al. Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNgamma+LPS), M(IL-4) and M(IL-10) phenotypes. J. Immunol. Methods 478, 112721 (2020).","journal-title":"J. Immunol. Methods"},{"key":"7006_CR85","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/mben.1998.0105","volume":"1","author":"UJ Balis","year":"1999","unstructured":"Balis, U. J. et al. Oxygen consumption characteristics of porcine hepatocytes. Metab. Eng. 1, 49\u201362 (1999).","journal-title":"Metab. Eng."},{"key":"7006_CR86","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3727\/000000007783464821","volume":"16","author":"X Stephenne","year":"2007","unstructured":"Stephenne, X. et al. Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1. Cell Transpl. 16, 409\u2013419 (2007).","journal-title":"Cell Transpl."},{"key":"7006_CR87","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1039\/C3LC51160J","volume":"14","author":"CJ Ochs","year":"2014","unstructured":"Ochs, C. J., Kasuya, J., Pavesi, A. & Kamm, R. D. Oxygen levels in thermoplastic microfluidic devices during cell culture. Lab Chip 14, 459\u2013462 (2014).","journal-title":"Lab Chip"},{"key":"7006_CR88","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.3748\/wjg.v11.i33.5095","volume":"11","author":"K Vekemans","year":"2005","unstructured":"Vekemans, K. & Braet, F. Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. World J. Gastroenterol. 11, 5095\u20135102 (2005).","journal-title":"World J. Gastroenterol."},{"key":"7006_CR89","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/jbm.a.35778","volume":"104","author":"AE Loneker","year":"2016","unstructured":"Loneker, A. E., Faulk, D. M., Hussey, G. S., D\u2019Amore, A. & Badylak, S. F. Solubilized liver extracellular matrix maintains primary rat hepatocyte phenotype in-vitro. J. Biomed. Mater. Res. A 104, 1846\u20131847 (2016).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"7006_CR90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymeth.2016.06.008","volume":"109","author":"M Oparka","year":"2016","unstructured":"Oparka, M. et al. Quantifying ROS levels using CM-H(2)DCFDA and HyPer. Methods 109, 3\u201311 (2016).","journal-title":"Methods"},{"key":"7006_CR91","doi-asserted-by":"publisher","unstructured":"Lefever, D. E. et al. A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies. Metabolites 12, https:\/\/doi.org\/10.3390\/metabo12060528 (2022).","DOI":"10.3390\/metabo12060528"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07006-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07006-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07006-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T08:10:20Z","timestamp":1728893420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07006-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7006"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-07006-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.22.590598","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.L.T., A.G., and M.E.S. have equity in Nortis, a company supplying MPS chips\/some automation and EveAnalytics (accessing, analyzing, and computationally modeling data on patient-derived microphysiology systems).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1317"}}